スポンサーリンク
21st Century Coe Program Kyoto Pharmaceutical University | 論文
- Investigation of Signaling Mechanisms Induced by Mitocryptides in Neutrophilic/granulocytic Cells
- Development of Biotin-Tagged Tubulin Photoaffinity Probes Derivatized from Diketopiperazine Based Anti-Microtubule Agents
- Cryptide Signaling and the Exocytotic Mechanisms Induced by Amphiphilic Peptides
- Click Peptide : Application to E22Δ-type Mutant of Amyloid β Peptide
- Click Peptide : In Situ Production of pyroGlu-Abeta from the O-Acyl Isopeptide
- Use of O-Acyl Isopeptides to Identify New Functions of Amyloid β Peptides
- Design and Preparation of the Tetrapeptides as Low Molecular Sized BACE1 Inhibitors
- Screening Methodology for Discovery of Inhibitory Peptides against Pathogenic Proteins using a Plug-plug Affinity Capillary Electrophoresis Technique
- Optimization of Peptidomimetic Plasmepsin Inhibitor Containing Allophenylnorstatine Using Basic Substituent for Malaria Treatment
- Design of BACE1 Inhibitors Containing 5-Nitro-Isophthalamide
- Can the substrate of an enzyme turn into its inhibitor by vastly-reduced k_ value?
- Phenyl(cyclo)alkylamines : Second generation P_1' position analogs for pentapeptidic BACE1 inhibitors
- Tripeptidic BACE1 Inhibitors by Conformational Structure-based Design
- Structure Activity Relationship Study of SARS Coronavirus 3CL Protease Inhibitors with an Electrophilic Aryl Ketone Structure
- Synthesis and Biological Evaluation of Dipeptidic Antibiotics (+)-Negamycin and Its Derivatives for Development of Duchenne Muscular Dystrophy Chemotherapy
- Isotope Labeling-assisted Quantitative Evaluation of Refolding Conditions of a Recombinant Disulfide Protein
- Intact Cell-based SPR Analyses of Interactions between EGF and its Receptor
- Development of Chemical Probes towards the Elucidation of Binding Mechanism of Plinabulin, a Cyclicdipeptide Based Anti-microtubule Agent
- Novel BACE1 inhibitors containing P_1-P_1' non-natural amino acid-guanidinyl analogues
- Design, Synthesis and Evalution of Tripeptidomimetics with Arylketone as Inhibitors of SARS-CoV 3CL Protease